# Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/dapagliflozin-effects-on-haematocrit-red-blood-cell-count-and-reticulocytes-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jens Aberle,Markus Menzen,Sebastian Schmid,Christoph Terkamp,Elmar Jaeckel,Katja Rohwedder,Markus F. Scheerer,John Xu,Weifeng Tang,Andreas L. Birkenfeld |
| Citations | 48 |
| DOI | 10.1038/s41598-020-78734-z |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://www.nature.com/articles/s41598-020-78734-z.pdf |
| OpenAlex ID | https://openalex.org/W3114988689 |
| PMID | 33372185 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Katja Rohwedder](https://scholariq.org/researchers/katja-rohwedder/)

## Paper journal

- [Scientific Reports](https://scholariq.org/journals/scientific-reports/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.